Neurologic 3D MR spectroscopic imaging with low-power adiabatic pulses and fast spiral acquisition.

PURPOSE To improve clinical three-dimensional (3D) MR spectroscopic imaging with more accurate localization and faster acquisition schemes. MATERIALS AND METHODS Institutional review board approval and patient informed consent were obtained. Data were acquired with a 3-T MR imager and a 32-channel head coil in phantoms, five healthy volunteers, and five patients with glioblastoma. Excitation was performed with localized adiabatic spin-echo refocusing (LASER) by using adiabatic gradient-offset independent adiabaticity wideband uniform rate and smooth truncation (GOIA-W[16,4]) pulses with 3.5-msec duration, 20-kHz bandwidth, 0.81-kHz amplitude, and 45-msec echo time. Interleaved constant-density spirals simultaneously encoded one frequency and two spatial dimensions. Conventional phase encoding (PE) (1-cm3 voxels) was performed after LASER excitation and was the reference standard. Spectra acquired with spiral encoding at similar and higher spatial resolution and with shorter imaging time were compared with those acquired with PE. Metabolite levels were fitted with software, and Bland-Altman analysis was performed. RESULTS Clinical 3D MR spectroscopic images were acquired four times faster with spiral protocols than with the elliptical PE protocol at low spatial resolution (1 cm3). Higher-spatial-resolution images (0.39 cm3) were acquired twice as fast with spiral protocols compared with the low-spatial-resolution elliptical PE protocol. A minimum signal-to-noise ratio (SNR) of 5 was obtained with spiral protocols under these conditions and was considered clinically adequate to reliably distinguish metabolites from noise. The apparent SNR loss was not linear with decreasing voxel sizes because of longer local T2* times. Improvement of spectral line width from 4.8 Hz to 3.5 Hz was observed at high spatial resolution. The Bland-Altman agreement between spiral and PE data is characterized by narrow 95% confidence intervals for their differences (0.12, 0.18 of their means). GOIA-W(16,4) pulses minimize chemical-shift displacement error to 2.1%, reduce nonuniformity of excitation to 5%, and eliminate the need for outer volume suppression. CONCLUSION The proposed adiabatic spiral 3D MR spectroscopic imaging sequence can be performed in a standard clinical MR environment. Improvements in image quality and imaging time could enable more routine acquisition of spectroscopic data than is possible with current pulse sequences.

[1]  David Bonekamp,et al.  Quantitative SENSE-MRSI of the human brain. , 2010, Magnetic resonance imaging.

[2]  A Ebel,et al.  Assessment of 3D proton MR echo‐planar spectroscopic imaging using automated spectral analysis , 2001, Magnetic resonance in medicine.

[3]  Roland Bammer,et al.  Fast parallel spiral chemical shift imaging at 3T using iterative SENSE reconstruction , 2008, Magnetic resonance in medicine.

[4]  Gioacchino Tedeschi,et al.  High Speed 1H Spectroscopic Imaging in Human Brain by Echo Planar Spatial‐Spectral Encoding , 1995, Magnetic resonance in medicine.

[5]  S. Posse,et al.  Cerebral N-acetylaspartate is low in patients with multiple sclerosis and abnormal visual evoked potentials. , 1998, AJNR. American journal of neuroradiology.

[6]  Andreas Ebel,et al.  Improved spectral quality for 3D MR spectroscopic imaging using a high spatial resolution acquisition strategy. , 2003, Magnetic resonance imaging.

[7]  Ray Freeman,et al.  Adiabatic pulses for wideband inversion and broadband decoupling , 1995 .

[8]  Costin Tanase,et al.  Rosette spectroscopic imaging: Optimal parameters for alias‐free, high sensitivity spectroscopic imaging , 2009, Journal of magnetic resonance imaging : JMRI.

[9]  R. B. Kingsley,et al.  WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. , 1994, Journal of magnetic resonance. Series B.

[10]  Jens Frahm,et al.  Spiral imaging: A critical appraisal , 2005, Journal of magnetic resonance imaging : JMRI.

[11]  Peter Mansfield Spatial mapping of the chemical shift in NMR , 1983 .

[12]  J Star-Lack,et al.  Reduced spatial side lobes in chemical‐shift imaging , 1999, Magnetic resonance in medicine.

[13]  Adolf Pfefferbaum,et al.  Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. , 2003, AJNR. American journal of neuroradiology.

[14]  Albert P. Chen,et al.  Compressed sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. , 2008, Journal of magnetic resonance.

[15]  Ewald Moser,et al.  High‐resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy‐matched voxel sizes , 2003, Magnetic resonance in medicine.

[16]  Y. Yen,et al.  In vivo application of sub-second spiral chemical shift imaging (CSI) to hyperpolarized 13C metabolic imaging: comparison with phase-encoded CSI. , 2010, Journal of magnetic resonance.

[17]  Thomas H. Mareci,et al.  Selective inversion radiofrequency pulses by optimal control , 1986 .

[18]  Michael Garwood,et al.  Improved Performance of Frequency-Swept Pulses Using Offset-Independent Adiabaticity , 1996 .

[19]  Dwight G. Nishimura,et al.  Rapid gridding reconstruction with a minimal oversampling ratio , 2005, IEEE Transactions on Medical Imaging.

[20]  Andreas Ebel,et al.  Comparison of inversion recovery preparation schemes for lipid suppression in 1H MRSI of human brain , 2003, Magnetic resonance in medicine.

[21]  Roger J Ordidge,et al.  Spin-echo MRS in humans at high field: LASER localisation using FOCI pulses. , 2005, Journal of magnetic resonance.

[22]  L DelaBarre,et al.  The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. , 2001, Journal of magnetic resonance.

[23]  Dennis W J Klomp,et al.  Short echo time 1H‐MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses , 2008, Magnetic resonance in medicine.

[24]  K. Uğurbil,et al.  NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K P Pruessmann,et al.  Sensitivity‐encoded spectroscopic imaging , 2001, Magnetic resonance in medicine.

[26]  Eva-Maria Ratai,et al.  Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners. , 2010, Journal of magnetic resonance.

[27]  Jeffry R Alger,et al.  Proton echo‐planar spectroscopic imaging with highly effective outer volume suppression using combined presaturation and spatially selective echo dephasing , 2003, Magnetic resonance in medicine.

[28]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[29]  Saadallah Ramadan,et al.  Neurospectroscopy: the past, present and future. , 2010, Chemical reviews.

[30]  A. Macovski,et al.  Variable-rate selective excitation , 1988 .

[31]  G. Sarty,et al.  Single TrAjectory Radial (STAR) imaging , 2004, Magnetic resonance in medicine.

[32]  Dong-Hyun Kim,et al.  Fast 3D 1H MRSI of the corticospinal tract in pediatric brain , 2009, Journal of magnetic resonance imaging : JMRI.

[33]  André J. W. van der Kouwe,et al.  Brain morphometry with multiecho MPRAGE , 2008, NeuroImage.

[34]  P. Bottomley Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[35]  Out‐and‐in spiral spectroscopic imaging in rat brain at 7 T , 2003, Magnetic resonance in medicine.

[36]  R. Ramsay,et al.  Application of volumetric MR spectroscopic imaging for localization of neocortical epilepsy , 2010, Epilepsy Research.

[37]  L. Wald,et al.  Accelerated proton echo planar spectroscopic imaging (PEPSI) using GRAPPA with a 32‐channel phased‐array coil , 2008, Magnetic resonance in medicine.

[38]  Ricardo Otazo,et al.  Sensitivity‐encoded (SENSE) proton echo‐planar spectroscopic imaging (PEPSI) in the human brain , 2007, Magnetic resonance in medicine.

[39]  M. Lustig,et al.  Compressed Sensing MRI , 2008, IEEE Signal Processing Magazine.

[40]  M. Lustig,et al.  Clinically Feasible Reconstruction Time for L 1-SPIRiT Parallel Imaging and Compressed Sensing MRI , 2009 .

[41]  S. Nelson Multivoxel magnetic resonance spectroscopy of brain tumors. , 2003, Molecular cancer therapeutics.

[42]  Adolf Pfefferbaum,et al.  Application of subsecond spiral chemical shift imaging to real‐time multislice metabolic imaging of the rat in vivo after injection of hyperpolarized 13C1‐pyruvate , 2009, Magnetic resonance in medicine.

[43]  Priti Balchandani,et al.  Fat suppression for 1H MRSI at 7T using spectrally selective adiabatic inversion recovery , 2008, Magnetic resonance in medicine.

[44]  A. Pfefferbaum,et al.  Reproducibility study of whole‐brain 1H spectroscopic imaging with automated quantification , 2008, Magnetic resonance in medicine.

[45]  S. Nelson Multivoxel magnetic resonance spectroscopy of brain tumors. , 2003, Molecular cancer therapeutics.

[46]  A. Macovski,et al.  Volumetric spectroscopic imaging with spiral‐based k‐space trajectories , 1998, Magnetic resonance in medicine.

[47]  Jesús Cid-Sueiro,et al.  Automatic placement of outer volume suppression slices in MR spectroscopic imaging of the human brain , 2010, Magnetic resonance in medicine.

[48]  G B Matson,et al.  Reduced phase encoding in spectroscopic imaging , 1994, Magnetic resonance in medicine.

[49]  J. Kurhanewicz,et al.  Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer , 2000, Magnetic resonance in medicine.

[50]  D M Spielman,et al.  Three‐Dimensional Spectroscopic Imaging with Time‐Varying Gradients , 1995, Magnetic resonance in medicine.

[51]  R. Ordidge,et al.  Frequency offset corrected inversion (FOCI) pulses for use in localized spectroscopy , 1996, Magnetic resonance in medicine.

[52]  B J Soher,et al.  Acute stroke: evaluation with serial proton MR spectroscopic imaging. , 1994, Radiology.

[53]  Michael Lustig,et al.  3D compressed sensing for highly accelerated hyperpolarized 13C MRSI with in vivo applications to transgenic mouse models of cancer , 2010, Magnetic resonance in medicine.